Výsledky vyhledávání - "Ivana Jaqueline Tapia"

Abstract 1078: Hypoxic microenvironment promotes resistance to targeted therapies in HER2-overexpressing breast cancer involving epithelial-to-mesenchymal transition features

Autor: Ezequiel Lacunza, Virginia Judith Wolos, Gabriel L. Fiszman, Ivana Jaqueline Tapia, Elisa Bal de Kier Joffé, Marianela Abrigo

Publikováno v: Cancer Research. 81:1078-1078

Trastuzumab and trastuzumab emtansine (T-DM1) targeted therapies are the main choice for the treatment of HER2-overexpressing breast cancer patients. However, de novo or acquired resistance is still the major obstacle in clinical practice. It has bee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f4b0b48b2e590e4c437cd75a720ab95
https://doi.org/10.1158/1538-7445.am2021-1078

Zobrazit plný text záznamu

Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine

Autor: José Mordoh, Gabriela Andrea Pizzurro, Leonardo Sganga, Osvaldo L. Podhajcer, Ivana Jaqueline Tapia, Maria Marcela Barrio

Publikováno v: Cancer Immunology, Immunotherapy. 64:1393-1406

Dendritic cells (DCs) are professional APCs used for the development of cancer vaccines because of their ability to activate adaptive immune responses. Previously, we designed the DC/Apo-Nec vaccine using human DCs loaded with dying melanoma cells th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e98a3cd6e036932bb478bb241ebfee
https://doi.org/10.1007/s00262-015-1743-z

Zobrazit plný text záznamu

Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators

Autor: Irene Larripa, María Sol Ruiz, Michele Bianchini, M. Medina, Jose Mordoh, Ivana Jaqueline Tapia, Nicholas C.P. Cross

Publikováno v: CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Leukemia

Residual disease in chronic myeloid leukemia (CML) patients undergoing therapy with tyrosine kinase inhibitors (TKIs) is measured by assessing the quantity of transcripts of the BCR-ABL1 fusion gene in peripheral white blood cells. This analysis is b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97cc790ab5d238e3ff9e544420eacd76
https://doi.org/10.1038/leu.2016.197

Zobrazit plný text záznamu

A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment

Autor: Ivana Jaqueline Tapia, Maria Marcela Barrio, Jose Mordoh

Publikováno v: BMC Cancer
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET

Background: Hormonal treatment might affect the immune response to tumor antigens induced in cancer patients who are being vaccinated. Case presentation: A 33 years-old woman was diagnosed with cutaneous melanoma in May 2009. Her melanoma was located

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67490bd220c737a22695fcd5e9083996

Zobrazit plný text záznamu

Elektronická kniha

Melanoma: Molecular Biology, Risk Factors and Treatment Options

Autor: Jones, Alexander C.

Melanoma accounts for only 4% of all skin cancer cases but most of skin cancer-related death. The rising incidence of melanoma makes this tumor an important public health problem. In this book, the authors present current research in the study of the

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání